Streetbeat News

ASPI

ASP Isotopes Inc. Common Stock

Industry

Chemicals

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

Open

4.31

Mkt cap

349M

Volume

3.3M

High

4.89

P/E Ratio

-8.29

52-wk high

9.33

Low

4.31

Div yield

N/A

52-wk low

1.65

Shareholders of ASP Isotopes Inc. (NASDAQ:ASPI) are encouraged to contact Levi & Korsinsky by February 3, 2025, to discuss potential recovery options under federal securities laws due to investment losses.

Portfolio Pulse from

December 23, 2024 | 1:45 am

Shareholders of ASP Isotopes Inc. (ASPI) who incurred losses are encouraged to contact Levi & Korsinsky for information on a potential class action lawsuit for recovery under federal securities laws.

Portfolio Pulse from

December 21, 2024 | 11:30 pm

ASP Isotopes Inc is facing a class action lawsuit for alleged violations of securities laws. The Schall Law Firm is urging affected shareholders to contact them. The lawsuit pertains to securities purchased between October 30, 2024, and November 26, 2024.

Portfolio Pulse from

December 21, 2024 | 6:30 pm

Faruqi & Faruqi, LLP is investigating claims on behalf of investors who suffered losses exceeding $50,000 in ASP Isotopes between October 30, 2024, and November 26, 2024. Investors are encouraged to contact the firm to discuss their legal options before the February 3, 2025 deadline.

Portfolio Pulse from

December 21, 2024 | 1:45 pm

A class action lawsuit has been filed against ASP Isotopes Inc. (NASDAQ:ASPI) seeking recovery for investors who suffered losses. Investors are encouraged to contact Levi & Korsinsky for more information on potential recovery under federal securities laws.

Portfolio Pulse from

December 20, 2024 | 9:45 pm

Glancy Prongay & Murray LLP is inviting investors with significant losses to lead a securities fraud class action lawsuit against ASP Isotopes Inc. The class period is from October 30, 2024, to November 26, 2024, with a lead plaintiff deadline of February 3, 2025.

Portfolio Pulse from

December 20, 2024 | 9:15 pm

Pomerantz Law Firm has filed a class action lawsuit against ASP Isotopes Inc. (NASDAQ: ASPI) and reminds shareholders with losses to take note of upcoming deadlines.

Portfolio Pulse from

December 20, 2024 | 9:15 pm

A class action lawsuit is pending against ASP Isotopes Inc. (ASPI) for investors who suffered losses. Investors are encouraged to contact Levi & Korsinsky for potential recovery under federal securities laws.

Portfolio Pulse from

December 20, 2024 | 7:00 pm

The Schall Law Firm has announced a class action lawsuit against ASP Isotopes Inc. for alleged securities fraud. Investors who purchased ASP Isotopes' securities between October 30, 2024, and November 26, 2024, are encouraged to participate in the lawsuit.

Portfolio Pulse from

December 20, 2024 | 6:30 pm

Levi & Korsinsky is inviting shareholders of ASP Isotopes Inc. (NASDAQ:ASPI) to discuss potential recovery options under federal securities laws if they have suffered losses. The deadline for contacting them is February 3, 2025.

Portfolio Pulse from

December 20, 2024 | 6:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.